Tg.2098 is a major human thyroglobulin T-cell epitope

Journal of Autoimmunity

Volumn 35, Issue 1, 2010, Pages 45-51

  Menconi, Francesca ^a   Huber, Amanda ^a   Osman, Roman ^a   Concepcion, Erlinda ^a   Jacobson, Eric M ^b   Stefan, Mihaela ^a   David, Chela S ^c   Tomer, Yaron ^a,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gene; HLA; Thyroglobulin; Thyroiditis

Indexed keywords

ARGININE; ASPARTIC ACID; EPITOPE; HLA DR ANTIGEN; HLA DR3 ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROGLOBULIN.2098; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 2; PEPTIDE FRAGMENT; PROTEIN BINDING;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE THYROIDITIS; BINDING AFFINITY; COMPLEX FORMATION; COMPUTER SIMULATION; CONTROLLED STUDY; EXON; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURFACE CHARGE; T LYMPHOCYTE ACTIVATION; TRANSGENE; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; EPITOPE MAPPING; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SECRETION (PROCESS); T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; CELL PROLIFERATION; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR3 ANTIGEN; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; POLYMORPHISM, GENETIC; PROTEIN BINDING; T-LYMPHOCYTES; THYROGLOBULIN; THYROIDITIS, AUTOIMMUNE;

EID: 77953264263     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.01.004     Document Type: Article

References (37)

1. Castellino F., Zhong G., Germain R.N. Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture. Hum Immunol 1997, 54(2):159-169.
2. Jacobson E.M., Huber A., Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 2008, 30(1-2):58-62.
3. Lee K.H., Wucherpfennig K.W., Wiley D.C. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol 2001, 2(6):501-507.
4. Wucherpfennig K.W. MHC-linked susceptibility to type 1 diabetes: a structural perspective. Ann N Y Acad Sci 2003, 1005:119-127.
5. Onengut-Gumuscu S., Concannon P. The genetics of type 1 diabetes: lessons learned and future challenges. J Autoimmun 2005, 25(Suppl.):34-39.
6. Todd J.A., Acha-Orbea H., Bell J.I., Chao N., Fronek Z., Jacob C.O., et al. A molecular basis for MHC class II - associated autoimmunity. Science 1988, 240(4855):1003-1009.
7. Gregersen P.K. HLA associations with rheumatoid arthritis: a piece of the puzzle. J Rheumatol Suppl 1992, 32:7-11.
8. Gregersen P.K., Silver J., Winchester R.J. Genetic susceptibility to rheumatoid arthritis and human leukocyte antigen class II polymorphism. The role of shared conformational determinants. Am J Med 1988, 85(6A):17-19.
9. Ban Y., Davies T.F., Greenberg D.A., Concepcion E.S., Osman R., Oashi T., et al. Arginine at position 74 of the HLA-DRb1 chain is associated with Graves' disease. Genes Immun 2004, 5:203-208.
10. Menconi F., Monti M.C., Greenberg D.A., Oashi T., Osman R., Davies T.F., et al. Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc Natl Acad Sci U S A 2008, 105(37):14034-14039.
11. Hodge S.E., Ban Y., Strug L.J., Greenberg D.A., Davies T.F., Concepcion E.S., et al. Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease. Thyroid 2006, 16(4):351-355.
12. Jacobson E.M., Yang H., Menconi F., Wang R., Osman R., Skrabanek L., et al. Employing a recombinant HLA-DR3 expression system to dissect MHC II- thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective. J Biol Chem 2009, [ePub].
13. Muixi L., Carrascal M., Alvarez I., Daura X., Marti M., Armengol M.P., et al. Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands. J Immunol 2008, 181(1):795-807.
14. Flynn J.C., McCormick D.J., Brusic V., Wan Q., Panos J.C., Giraldo A.A., et al. Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. Cell Immunol 2004, 229(2):79-85.
15. Kong Y.M., David C.S., Lomo L.C., Fuller B.E., Motte R.W., Giraldo A.A. Role of mouse and human class II transgenes in susceptibility to and protection against mouse autoimmune thyroiditis. Immunogenetics 1997, 46(4):312-317.
16. Bradley D.S., Nabozny G.H., Cheng S., Zhou P., Griffiths M.M., Luthra H.S., et al. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J Clin Invest 1997, 100(9):2227-2234.
17. Dixit S.B., Beveridge D.L., Case D.A., Cheatham T.E., Giudice E., Lankas F., et al. Molecular dynamics simulations of the 136 unique tetranucleotide sequences of DNA oligonucleotides. II: sequence context effects on the dynamical structures of the 10 unique dinucleotide steps. Biophys J 2005, 89(6):3721-3740.
18. Beveridge D.L., Barreiro G., Byun K.S., Case D.A., Cheatham T.E., Dixit S.B., et al. Molecular dynamics simulations of the 136 unique tetranucleotide sequences of DNA oligonucleotides. I. Research design and results on d(CpG) steps. Biophys J 2004, 87(6):3799-3813.
19. Gohlke H., Case D.A. Converging free energy estimates: MM-PB(GB)SA studies on the protein-protein complex Ras-Raf. J Comput Chem 2004, 25(2):238-250.
20. Gohlke H., Kiel C., Case D.A. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J Mol Biol 2003, 330(4):891-913.
21. Jacobson E.M., Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 2007, 28:85-98.
22. Farid N.R., Bear J.C. The human major histocompatibility complex and endocrine disease. Endocr Rev 1981, 2:50-86.
23. Moens H., Farid N.R., Sampson L., Noel E.P., Barnard J.M. Hashimoto's thyroiditis is associated with HLA-DRw3. N Engl J Med 1978, 299:133-134.
24. Tandon N., Zhang L., Weetman A.P. HLA associations with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1991, 34:383-386.
25. Ban Y., Davies T.F., Greenberg D.A., Concepcion E.S., Tomer Y. The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families. Clin Endocrinol (Oxf) 2002, 57(1):81-88.
26. Tomer Y., Ban Y., Concepcion E., Barbesino G., Villanueva R., Greenberg D.A., et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 2003, 73:736-747.
27. Tomer Y., Greenberg D.A., Concepcion E., Ban Y., Davies T.F. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J Clin Endocrinol Metab 2002, 87(1):404-407.
28. Collins J.E., Heward J.M., Carr-Smith J., Daykin J., Franklyn J.A., Gough S.C.L. Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J Clin Endocrinol Metab 2003, 88:5039-5042.
29. Ban Y., Tozaki T., Taniyama M., Tomita M., Ban Y. Association of a thyroglobulin gene polymorphism with Hashimoto's thyroiditis in the Japanese population. Clin Endocrinol (Oxf) 2004, 61(2):263-268.
30. Hsiao J.Y., Hsieh M.C., Tien K.J., Hsu S.C., Shin S.J., Lin S.R. Association between a C/T polymorphism in exon 33 of the thyroglobulin gene is associated with relapse of Graves' hyperthyroidism after antithyroid withdrawal in Taiwanese. J Clin Endocrinol Metab 2007, 92(8):3197-3201.
31. Tomer Y., Menconi F., Davies T.F., Barbesino G., Rocchi R., Pinchera A., et al. Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis. J Autoimmun 2007, 29(2-3):69-77.
32. Ban Y., Greenberg D.A., Concepcion E., Skrabanek L., Villanueva R., Tomer Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci U S A 2003, 100:15119-15124.
33. Hatzioannou A., Liakata E., Karras E., Thrasyvoulides A., Alevizaki M., Lymberi P. Pathogenicity of a human thyroglobulin peptide (2340-2359) in mice with high or low genetic susceptibility to thyroiditis. Immunology 2007, 122(3):343-349.
34. Li H.S., Jiang H.Y., Carayanniotis G. Modifying effects of iodine on the immunogenicity of thyroglobulin peptides. J Autoimmun 2007, 28(4):171-176.
35. Verginis P., Stanford M.M., Carayanniotis G. Delineation of five thyroglobulin T cell epitopes with pathogenic potential in experimental autoimmune thyroiditis. J Immunol 2002, 169(9):5332-5337.
36. Nakachi K., Powell M., Swift G., Amoroso M.A., Ananieva-Jordanova R., Arnold C., et al. Epitopes recognised by tissue transglutaminase antibodies in coeliac disease. J Autoimmun 2004, 22(1):53-63.
37. Rief S., Lerner A. Tissue transglutaminase - the key player in celiac disease: a review. Autoimmun Rev 2004, 3:40-45.